Comparison of Abbott Fluorescence Polarization Immunoassay (FPIA) and Roche Radioimmunoassay for the Analyses of Cannabinoids in Urine Specimens

    Volume 37, Issue 2 (March 1992)

    ISSN: 0022-1198

    CODEN: JFSOAD

    Page Count: 4


    Xu, A
    Laboratory superintendent, chief—Forensic Toxicology Laboratory, chemist, and chief—Division of Forensic Toxicology, Division of Toxicology, Armed Forces Institute of Pathology, Washington, DC

    Levine, B
    Laboratory superintendent, chief—Forensic Toxicology Laboratory, chemist, and chief—Division of Forensic Toxicology, Division of Toxicology, Armed Forces Institute of Pathology, Washington, DC

    Smith, ML
    Laboratory superintendent, chief—Forensic Toxicology Laboratory, chemist, and chief—Division of Forensic Toxicology, Division of Toxicology, Armed Forces Institute of Pathology, Washington, DC

    Budgett, WT
    Laboratory superintendent, chief—Forensic Toxicology Laboratory, chemist, and chief—Division of Forensic Toxicology, Division of Toxicology, Armed Forces Institute of Pathology, Washington, DC

    (Received 21 March 1991; accepted 26 July 1991)

    Abstract

    Abbott fluorescence polarization immunoassay (FPIA) and Roche Abuscreen radioimmunoassay (RIA) were compared qualitatively with 142 urine specimens containing 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid. Similar qualitative results were obtained in 132 specimens. When discrepent results were observed, all negative results were within 20% of the 100 ng/mL cut-off. We concluded that FPIA and RIA give comparable results to each other.


    Paper ID: JFS13271J

    DOI: 10.1520/JFS13271J

    ASTM International
    is a member of CrossRef.

    Author
    Title Comparison of Abbott Fluorescence Polarization Immunoassay (FPIA) and Roche Radioimmunoassay for the Analyses of Cannabinoids in Urine Specimens
    Symposium , 0000-00-00
    Committee E30